Portfolio company
VisusNano
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This company develops drug-eluting intraocular lens implants for patients undergoing cataract surgery to eliminate the need for post-operative eye drops.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Adaptilens
Adaptilens develops flexible intraocular lenses that mimic the natural focus of the eye for patients undergoing cataract surgery to eliminate dependence on glasses.
SpyGlass Pharma, Inc
The company develops an intraocular lens drug delivery system for patients with glaucoma to provide long-term medication during cataract surgery.
EyeYon
This company develops synthetic corneal implants and therapeutic contact lenses for patients with corneal diseases, providing alternatives to traditional donor tissue transplants.
Aquesys
This company develops and manufactures ocular implants for glaucoma patients to reduce intraocular pressure through minimally invasive surgical procedures.
Azalea Vision
This company develops smart contact lenses with integrated microelectronics to treat patients suffering from vision disorders and light sensitivity.
Glakolens
This company develops sensor-embedded contact lenses that provide continuous intraocular pressure monitoring for patients with glaucoma and ocular hypertension.
INEYE Therapeutics
This company develops ocular drug delivery inserts to treat chronic eye conditions such as dry eye and glaucoma for patients.
VISUfarma
This company develops and commercialises ophthalmic pharmaceuticals and medical devices for patients with eye conditions like glaucoma and dry eye disease.
